CCI vs SER · P/E 40, rev $6.57B vs rev $56.0K
Crown Castle (CCI) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. SER currently screens at market cap $29.7M.
Not investment advice. Open the CCI and SER stock pages for the full models.
Not investment advice.